US Treasury Hits Back On Inversions; Will Pfizer Fold?
This article was originally published in The Pink Sheet Daily
Executive Summary
Treasury announced new regulations aimed at blocking tax-motivated deals, leaving the largest mega-deal in the history of pharma hanging in the balance.